iuvo BioScience, Industry-Leading Pre-Clinical Research Organization, Acquires Oculos Clinical Research
Combined expertise and experience creates fully integrated, research to release, ophthalmic development services company.
July 9, 2018 - Rush, New York and Tampa, Florida – iuvo BioScience, an industry leading R&D services company specializing in safety, microbiology, toxicology, and analytical chemistry testing for the medical device and pharmaceutical industries, announced today that it has added Oculos Clinical Research, a leader in ophthalmic clinical research, to its corporate organization.
iuvo Completes Four Successful Regulatory Inspections
June 29, 2018 – RUSH, NY - iuvo BioScience is proud to announce that, in a span of two weeks, the company hosted and passed re-accreditation inspections from the following agencies and for the following standards:
iuvo CSO Mary Richardson Receives United Way Shining Star Award
June 12, 2018 – As iuvo recently wrapped up its 2018 United Way Campaign, iuvo’s Chief Scientific Officer Mary Richardson received a Shining Star award from the United Way of Greater Rochester in recognition for her commitment and leadership to this program.
Dr. Mary Richardson Presenting at PQRI Extractables and Leachables Workshop
April 16, 2018 – iuvo BioScience’s Chief Scientific Officer Dr. Mary Richardson will be presenting on ophthalmic drug products considerations for E&L studies at the Product Quality Research Institute Extractables and Leachables Workshop this week.
iuvo Attending SOT ToxExpo, March 11-15, 2018
March 2, 2018 - iuvo BioScience will be attending the 57th Annual Meeting and ToxExpo for the Society of Toxicology, March 11-15, 2018.
The meeting will be held at the Henry B. Gonzalez Convention Center in San Antonio, Texas.
We look forward to seeing you there!
Dr. Kathleen Krenzer Chosen VP-Elect of Ocular Toxicity Specialty Section of the SOT
NOVEMBER 15, 2017 - Dr. Kathleen Krenzer, iuvo BioScience’s Research Fellow in Toxicology, was recently chosen as the Vice President-Elect of the Ocular Toxicity Specialty Section of the Society of Toxicology.
iuvo CSO Mary Richardson Named Finalist for ATHENA Award
November 8, 2017 - iuvo BioScience is proud to announce that our Chief Scientific Officer, Dr. Mary Richardson, was named a finalist for the 2018 ATHENA Awards. The ATHENA Awards are presented by the Greater Rochester Chamber of Commerce and is awarded annually to a professional female leader who has demonstrated achievements in business, community service and the professional advancement of women.
iuvo CEO Ben Burton Named to MedTech Board of Directors
NOVEMBER 5, 2017 - iuvo BioScience announced today that iuvo’s President and CEO Ben Burton was named to the Board of Directors of MedTech at the MedTech 2017 Annual Meeting.
iuvo Attending American College of Toxicology, November 5-8
November 1, 2017 - iuvo BioScience announced today that the company will be attending the 38th Annual Meeting of the American College of Toxicology next week, November 5-8, 2017.